Compare BLLN & OUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | OUT |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.3B |
| IPO Year | 2025 | 2013 |
| Metric | BLLN | OUT |
|---|---|---|
| Price | $93.00 | $29.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $126.71 | $28.50 |
| AVG Volume (30 Days) | 797.8K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.94% |
| EPS Growth | ★ 103.40 | N/A |
| EPS | 0.48 | ★ 0.54 |
| Revenue | $305,112,000.00 | ★ $1,831,700,000.00 |
| Revenue This Year | $46.29 | $6.19 |
| Revenue Next Year | $30.14 | $3.08 |
| P/E Ratio | $198.23 | ★ $55.69 |
| Revenue Growth | ★ 99.97 | 0.04 |
| 52 Week Low | $61.96 | $16.97 |
| 52 Week High | $150.44 | $34.96 |
| Indicator | BLLN | OUT |
|---|---|---|
| Relative Strength Index (RSI) | 39.93 | 41.71 |
| Support Level | $88.38 | $30.14 |
| Resistance Level | $95.82 | $33.57 |
| Average True Range (ATR) | 4.51 | 0.57 |
| MACD | 0.13 | 0.07 |
| Stochastic Oscillator | 47.48 | 46.56 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The company has two reportable operating segments: Billboard and Transit. It derives maximum revenue from Billboard Segment. The company geographically operates in United States and Canada, of which United States derive maximum revenue.